HIGHCAT-Identification of patients at HIGH risk of developing urological cancer and Cancer-Associated Thrombosis based on innovative clinical markers and liquid biopsy.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
INSTITUTO DE SALUD CARLOS III
PILAR MEDINA BADENES
Resultados del Ensayo Clínico
Validation of urine p-cresol glucuronide as renal cell carcinoma non-invasive biomarker
Article. 10.1016/j.jprot.2024.105357. 2025
Portal de investigación